BCR and breast cancer: Our hypothesis is that, in CML, Aurora kinase A together with PLK1 may cooperate with the constitutively activated BCR::ABL1 tyrosine kinase promoting the occurrence of additional genetic and genomic alterations that may be direct or indirect drivers of TKIs resistance and disease progression to blast crisis (BC).